| Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A R Kruse‐Jarres, J St‐Louis, A Greist, A Shapiro, H Smith, P Chowdary, ... Haemophilia 21 (2), 162-170, 2015 | 199 | 2015 |
| Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus H Smith, IM Chen, R Kubo, KSK Tung Science 245 (4919), 749-752, 1989 | 183 | 1989 |
| Tolerance mechanism in experimental ovarian and gastric autoimmune diseases. H Smith, YH Lou, P Lacy, KS Tung Journal of immunology (Baltimore, Md.: 1950) 149 (6), 2212-2218, 1992 | 151 | 1992 |
| Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. H Smith, Y Sakamoto, K Kasai, KS Tung Journal of immunology (Baltimore, Md.: 1950) 147 (9), 2928-2933, 1991 | 109 | 1991 |
| Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome L Covic, C Singh, H Smith, A Kuliopulos Thrombosis and haemostasis 87 (04), 722-727, 2002 | 106 | 2002 |
| T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice. HP Smith, P Le, DL Woodland, MA Blackman Journal of immunology (Baltimore, Md.: 1950) 149 (3), 887-896, 1992 | 87 | 1992 |
| Frequency of platelet type versus type 2B von Willebrand disease A Hamilton, M Ozelo, J Leggo, C Notley, H Brown, JP Frontroth, ... Thrombosis and haemostasis 105 (03), 501-508, 2011 | 74 | 2011 |
| Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. GS Wengler, RC Allen, O Parolini, H Smith, ME Conley Journal of immunology (Baltimore, Md.: 1950) 150 (2), 700-704, 1993 | 65 | 1993 |
| Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. DL Woodland, HP Smith, S Surman, P Le, R Wen, MA Blackman The Journal of experimental medicine 177 (2), 433-442, 1993 | 58 | 1993 |
| Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab. AV Danilov, H Smith, S Craigo, DM Feeney, V Relias, KB Miller Leukemia Research 33 (6), e4-5, 2008 | 47 | 2008 |
| Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab AV Danilov, RA Brodsky, S Craigo, H Smith, KB Miller Leukemia research 34 (5), 566-571, 2010 | 45 | 2010 |
| Cost-effectiveness of autologous hematopoietic stem cell transplantation for elderly patients with multiple myeloma using the Surveillance, Epidemiology, and End Results … GL Shah, AN Winn, PJ Lin, A Klein, KA Sprague, HP Smith, R Buchsbaum, ... Biology of Blood and Marrow Transplantation 21 (10), 1823-1829, 2015 | 44 | 2015 |
| A dose‐escalation phase IIa study of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease A Kutlar, ME Reid, A Inati, AT Taher, MR Abboud, A El‐Beshlawy, ... American journal of hematology 88 (11), E255-E260, 2013 | 39 | 2013 |
| Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia J Cortes, M Talpaz, HP Smith, DS Snyder, J Khoury, KN Bhalla, ... Haematologica 102 (3), 519, 2017 | 31 | 2017 |
| Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice. MA Blackman, HP Smith, P Le, DL Woodland Journal of immunology (Baltimore, Md.: 1950) 151 (2), 556-565, 1993 | 31 | 1993 |
| Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis KS Esham, AM Rodday, HP Smith, F Noubary, RA Weidner, ... Blood advances 4 (1), 19-27, 2020 | 27 | 2020 |
| Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly … G Shah, E Kaul, S Fallo, F Cossor, H Smith, K Sprague, A Klein, K Miller, ... Clinical therapeutics 35 (10), 1614-1620, 2013 | 26 | 2013 |
| Paraproteinemia-associated scleredema treated successfully with intravenous immunoglobulin AB Eastham, AN Femia, NF Velez, HP Smith, RA Vleugels JAMA dermatology 150 (7), 788-789, 2014 | 25 | 2014 |
| A phase 1 study of DCC-2036, a novel oral inhibitor of BCR-ABL kinase, in patients with Philadelphia chromosome positive (Ph+) leukemias including patients with T315I mutation JE Cortes, M Talpaz, HM Kantarjian, H Smith, D Bixby, U Rafferty, ... Blood 118 (21), 601, 2011 | 23 | 2011 |
| Myelodysplastic syndrome and autoimmunity: a case report of an unusual presentation of myelodysplastic syndrome AL Merrill, H Smith Case reports in hematology 2011 (1), 560106, 2011 | 21 | 2011 |
